Six Additional Weeks of Rivaroxaban Reduces Recurrent VTE
WEDNESDAY, Nov. 30, 2022 (HealthDay News) — For patients with isolated distal deep venous...
Read MoreNov 30, 2022
WEDNESDAY, Nov. 30, 2022 (HealthDay News) — For patients with isolated distal deep venous...
Read MoreNov 30, 2022
WEDNESDAY, Nov. 30, 2022 (HealthDay News) — A subcutaneously implanted, catheter-pump system...
Read MoreNov 30, 2022
TUESDAY, Nov. 29, 2022 (HealthDay News) — Melanoma diagnosis is associated with increased...
Read MoreNov 30, 2022
TUESDAY, Nov. 29, 2022 (HealthDay News) — Tamoxifen treatment is associated with increased...
Read MoreNov 30, 2022
TUESDAY, Nov. 29, 2022 (HealthDay News) — For caregivers of patients with hematologic...
Read MoreNov 29, 2022
MONDAY, Nov. 28, 2022 (HealthDay News) — For patients with high-risk resected melanoma,...
Read MoreNov 29, 2022
MONDAY, Nov. 28, 2022 (HealthDay News) — The U.S. Food and Drug Administration has approved...
Read MoreNov 29, 2022
MONDAY, Nov. 28, 2022 (HealthDay News) — Survivors of childhood cancer who consume more...
Read MoreNov 24, 2022
The Food and Drug Administration (FDA) granted accelerated approval to the drug belantamab...
Read MoreNov 24, 2022
Because BRAF activating mutations have been found in so many different types of cancer, there has...
Read MoreNov 24, 2022
In spite of recent advances, pancreatic ductal adenocarcinoma (PDAC) is still extremely difficult...
Read MoreNov 23, 2022
WEDNESDAY, Nov. 23, 2022 (HealthDay News) — For newly diagnosed chronic-phase chronic...
Read MoreNov 23, 2022
TUESDAY, Nov. 22, 2022 (HealthDay News) — Most adults (83 percent) are unaware of the signs...
Read MoreNov 23, 2022
TUESDAY, Nov. 22, 2022 (HealthDay News) — The number of new cases of lung cancer decreased...
Read MoreNov 22, 2022
TUESDAY, Nov. 22, 2022 (HealthDay News) — About 10 percent of patients with appendix cancer...
Read MoreNov 22, 2022
TUESDAY, Nov. 22, 2022 (HealthDay News) — There is a significant treatment attrition rate in...
Read MoreNov 22, 2022
MONDAY, Nov. 21, 2022 (HealthDay News) — Most pivotal trials of new cancer, cardiovascular,...
Read MoreNov 21, 2022
MONDAY, Nov. 21, 2022 (HealthDay News) — For prostate cancer patients with a solitary...
Read MoreNov 21, 2022
MONDAY, Nov. 21, 2022 (HealthDay News) — Adverse effects associated with antibody-drug...
Read MoreNov 19, 2022
FRIDAY, Nov. 18, 2022 (HealthDay News) — The U.S. Food and Drug Administration is warning...
Read More